Symptoms and signs: There has been no experience of overdosage in clinical studies with DARZALEX FASPRO subcutaneous formulation.
Treatment: There is no known specific antidote for DARZALEX FASPRO overdose. In the event of an overdose, the patient should be monitored for any signs or symptoms of adverse effects and appropriate symptomatic treatment be instituted immediately.